Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03916926 · ClinicalTrials.gov registry record · NA

Older Adult Effectiveness of 2 Treatments

A NA study, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
568
Enrollment target

NCT03916926: Completed NA study, sponsored by Case Western Reserve University.

NCT03916926 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 568 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03916926, a NA study, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
568 participants
Enrollment target

Study Summary

The study is a cluster randomized clinical trial (RCT) to be conducted in 40 (22 originally planned +16 additional) publicly subsidized housing facilities/sites (HUD Section 202) and other low-income housing voucher programs in NE Ohio. The facilities will be randomized to 2 arms: Arm 1 (20 sites) - Participants will receive biannual silver diamine fluoride (SDF) versus Arm 2 (20 sites): Participants will receive atraumatic restorative treatment (ART) with glass ionomer cement (GIC) + biannual fluoride varnish (FV) application. A total of 590 (550 originally planned + 40 additional) participants (Arm 1: 295, Arm 2: 295) will be followed for one year (baseline, 26 weeks, 52 weeks). The protocol for each arm will address both coronal and root surface tooth decay lesions: Arm 1: The treatment will be bi-annual topical 38% SDF(Advantage Arrest, Elevate Oral Care LLC., West Palm Beach, FL) following manufacturer's instructions and published guidelines; Arm 2: The treatment will be ART will be a modification where the cavity will be restored with high viscosity glass-ionomer cement (GIC) (GC Fuji Automix LC Resin Reinforced Glass Ionomer Restorative, Japan)). Patients will also receive biannual topical fluoride varnish treatments (FluoriMax, Elevate) according to manufacturer's instructions.

Primary Outcome

International Caries Detection and Assessment System was the standard used to identify active caries lesions by examination at baseline by calibrated dental hygienists. ICDAS examination was then used to assess caries arrest on permanent tooth surfaces with moderate to severe lesions (ICDAS codes 3-6 with activity code 2 (active)) that received SDF or ART + FV treatment baseline. A lesion was considered arrested if, at follow-up, the activity code is 1 (inactive) or the surface is sound (code S

Interventions

  • DEVICE A "simple medical strategy" consisting of silver diamine fluoride (SDF)
  • DEVICE B "typical dental strategy" consisting of atraumatic restorative treatment (ART) with glass ionomer cement + Fluoride varnish (FV)

Trial Details

FieldValue
Enrollment Target 568 participants
Start Date 2019-09-18
Est. Completion 2024-06-07
Phase NA
Case Western Reserve University

141 total trials

What the finished NCT03916926 record still lists

NCT03916926 is an interventional study that assigns participants to a tested intervention. The registered 568 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).

The record links to 0 conditions, and to 2 interventions - of which A "simple medical strategy" consisting of silver diamine fluoride (SDF) is the first listed.

NCT03916926 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03916926 about?

NCT03916926 is a clinical study titled "Older Adult Effectiveness of 2 Treatments". The study is a cluster randomized clinical trial (RCT) to be conducted in 40 (22 originally planned +16 additional) publicly subsidized housing facilities/sites (HUD Section 202) and other low-income housing voucher programs in NE Ohio. The facilities will be randomized to 2 arms: Arm 1 (20 sites) -...

What is the current status of trial NCT03916926?

This trial is currently completed. It is a NA study. The enrollment target is 568 participants. The study started on 2019-09-18. Estimated completion is 2024-06-07.

What interventions are being tested in trial NCT03916926?

The interventions under investigation include: A "simple medical strategy" consisting of silver diamine fluoride (SDF) (DEVICE), B "typical dental strategy" consisting of atraumatic restorative treatment (ART) with glass ionomer cement + Fluoride varnish (FV) (DEVICE).

Who is sponsoring clinical trial NCT03916926?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03916926's enrollment target sits among peer trials

568 180th of 2000 higher than 1,821 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05472441 · 568 participants · NA

    Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)

  • NCT05000645 · 570 participants · NA

    Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women

  • NCT06239844 · 570 participants · NA

    Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English

  • NCT06701903 · 570 participants · Phase 2

    Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03916926, the US trial registry maintained by the National Library of Medicine. NCT03916926 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.